Clinical Trials Logo

Contraction clinical trials

View clinical trials related to Contraction.

Filter by:
  • None
  • Page 1

NCT ID: NCT04845295 Completed - Hypertrophy Clinical Trials

Resistance Training Effects on Muscle Morphological, Mechanical and Contractile Properties

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

The aim of the research project is to investigate the influence of resistance-training prescription (repetition duration, time under tension and training volume) and sex have on morpho-functional adaptations of upper and lower-body skeletal muscles. Twenty-four male and female university students were randomly assigned to one of two experimental groups, based on the repetition duration : "fast" group (with 1 second for eccentric and concentric phase) and "slow" group with prolonged duration of eccentric contraction (4 seconds for eccentric and 1 second concentric phase). At baseline and final measurement, cross-section area, one-repetition maximum and tensiomyography parameters (contraction time - Tc and radial displacement - Dm) of elbow flexors (biceps brachii) and knee extensors (4 quadriceps muscles) were evaluated.

NCT ID: NCT03963674 Enrolling by invitation - Clinical trials for Myofascial Pain Syndrome

Effects of Diacutaneous Fibrolysis Over Neuromuscular Response

Start date: February 5, 2019
Phase: N/A
Study type: Interventional

The study consists in evaluating the neuromuscular response of the gastrocnemious muscles before and after a diacutaneous fibrolysis over the gastrocnemious muscles.

NCT ID: NCT03940365 Completed - Labor Pain Clinical Trials

Fetal Life: Smart-Device Based Uterine Activity Monitoring

Start date: May 15, 2019
Phase: N/A
Study type: Interventional

This study will compare the performance of a contraction monitor (tocometer) device developed by Fetal Life with standard tocometer devices. The study aims to test a uterine contraction monitor that can be applied by the patient to her abdomen and connected to her smart device to detect the frequency and duration of uterine contractions. Phase 1 will collect data for calibration of the monitor and for a noninferiority study comparing the Fetal Life uterine contraction monitor (tocometer) with standard tocometry devices. Phase 2 will be a feasibility study in which patients will position the monitor, connect to the corresponding Fetal Life app and measure their own uterine contraction activity. The study's hypothesis is that after calibration, the new monitor will reliably detect at least 95% of the number and duration of contractions detected by the standard monitor, and that the device will perform comparably whether applied by the patient or by research staff.

NCT ID: NCT03319095 Completed - Muscle Clinical Trials

Intravaginal Electrical Nerve Stimulation in Women With Non-contracting Pelvic Floor

Start date: December 12, 2017
Phase: N/A
Study type: Interventional

It is estimated that about 30% of women cannot voluntarily contract the pelvic floor muscles (PFM). PFM training (PFMT) represents the first therapeutic option for the treatment of female urinary incontinence (UI), however the inability to contract this muscle makes PFMT unfeasible. The primary objective of this project is to evaluate clinically the efficacy of intravaginal electrical stimulation associated with verbal instructions to provide the ability of women to contract voluntary their PFM. The secondary objective is to evaluate the UI prevalence and impact on quality of life.

NCT ID: NCT02993354 Completed - Contraction Clinical Trials

Noninvasive Monitoring of Uterine Electrical Activity and Fetal Heart Rate: A New External Monitoring Device

EUM
Start date: July 1, 2017
Phase:
Study type: Observational

The EUM (electrical uterine myography) (OB Tools, Israel) was tested and found to be reliable as a non-invasive method for evaluating uterine contractions and the fetal heart rate. It is safe and effective in monitoring uterine contractions. The investigators propose to perform a study to validate the accuracy and clinical usefulness of the EUM device by simultaneously monitoring obese patients with current method of external tocodynamometry with the EUM device. Providers will be blinded to the results of the EUM device. Caregivers will continue care as per current guidelines using the information obtained from the current monitoring methods. Information obtained from the EUM devices will not be used to determine the clinical course of action.